Product Name

Trilostane

Name: Trilostane - LGM Pharma
SKU: 13647-35-3

CAS Number

13647-35-3

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:

Trilostane

CAS Number:

13647-35-3

Indication:

Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.

Mode of Action:

Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5, 4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.

Pharmacodynamics:

Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland. This product was withdrawn from the U.S. market in April 1994.

Metabolism:

Hepatic.

Toxicity:

Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.

IUPAC:

(1S, 2R, 6R, 8S, 11S, 12S, 15S, 16S)-5, 15-dihydroxy-2, 16-dimethyl-7-oxapentacyclo[9.7.0.0, {2, 8}.0, {6, 8}.0, {12, 16}]octadec-4-ene-4-carbonitrile

ATC:

H02CA01

DrugBank:

DB01108 (APRD01276)

Formula:

C₁₄H₁₈N₄O₃

Molecular Mass:

329.4333

SMILES:

C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O

InChi:

KVJXBPDAXMEYOA-CXANFOAXSA-N

General Reference:

Komanicky P, Spark RF, Melby JC: Treatment of Cushingês syndrome with trilostane (WIN 24, 540), an inhibitor of adrenal steroid biosynthesis. J Clin Endocrinol Metab. 1978 Nov;47(5):1042-51. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210.

Ask us about this product

API’s From Quality Manufacturers:

Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
Premium quality GMP certified and fully accredited API manufacturing plants
Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
Regulatory and technical assistance towards any submission type based on specific customer requirements

Trilostane

13647-35-3

Ask us about this product

API’s From Quality Manufacturers:

Find an API Product